Drug Profile
Enterovirus A vaccine - Adimmune/Medigen Vaccine Biologics
Alternative Names: EV-71 vaccine; EV71 vaccine inactivated - Medigen; Inactive whole monovalent EV71 virion vaccineLatest Information Update: 17 Oct 2022
Price :
$50
*
At a glance
- Originator National Health Research Institutes
- Developer Adimmune Corporation; Medigen Vaccine Biologics; National Health Research Institutes
- Class Enterovirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Enterovirus A infections
Most Recent Events
- 11 Dec 2021 Medigen Vaccine Biologics completes an observational extension trial in Enterovirus A infections (Prevention, In children) in Taiwan (FU-EV21e; NCT04072276)
- 16 Apr 2021 Medigen Vaccine Biologics completes a phase III clinical trial in Enterovirus A infections (In children, In infants, Prevention) in Taiwan and Vietnam (IM) (NCT03865238)
- 04 Sep 2019 Medigen Vaccine Biologics plans an observational extension trial in Enterovirus A infections (Prevention, In children) in Taiwan (FU-EV21e; NCT04072276)